MENU

CNSY Cerenome Inc Forecast, Technical & Fundamental Analysis

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

CNSY is expected to report earnings to fall 25.19% to -98 cents per share on October 29

Cerenome Inc CNSY Stock Earnings Reports
Q3'26
Est.
$-0.98
Q2'26
Missed
by $1.18
The last earnings report on August 14 showed earnings per share of -130 cents, missing the estimate of -12 cents. With 22.83K shares outstanding, the current market capitalization sits at 13.36M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EUVX11.510.61
+5.55%
Corgi Lithography & Semiconductor Photonics 2x Daily ETF (EUVX)
IVOG136.250.85
+0.63%
Vanguard S&P Mid-Cap 400 Growth ETF (IVOG)
TDSC28.850.04
+0.14%
ETC Cabana Target Drawdown 10 ETF (TDSC)
IVVW45.100.04
+0.09%
iShares S&P 500 BuyWrite ETF (IVVW)
OGSP9.92N/A
N/A
Obra High Grade Structured Products ETF (OGSP)
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
6420 Levit Green Boulevard
Phone
+1 210 974-6900
Employees
28
Web
https://www.cerenome.com
Cerenome (CNSY) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com